Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease have?

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease has 190 citations in the OpenAlex counts ScholarIQ stores.

When was Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease published?

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease has 2016 year in the ScholarIQ index.

What is the open-access status of Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease?

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease has hybrid oa status in the ScholarIQ index.

What is the DOI of Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease?

The DOI for Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease is on the source record.

What is the PMID of Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease?

The PMID for Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease is on the source record.

What is the OpenAlex record for Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease?

The OpenAlex for Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease is on the source record.